Discover the full record of transactions filed by Harris Matthew Scott, Directeur Médical. Officer active across 1 companies, notably Altimmune, Inc.. Aggregated, 5 filings have been published. The latest transaction was filed on 28 February 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Matthew Scott Harris is the Chief Medical Officer at Altimmune, Inc. He is responsible for leading medical and research initiatives. Matthew plays a key role in developing new treatments and improving patient outcomes.